MEDANTANSEGlobal Health LimitedMediumNeutral
Announced Mon, 27 Apr · 14:41 IST

Global Health Limited has informed the Exchange regarding Outcome of Board Meeting held on April 27, 2026.

Listed Co AcquisitionStrategic Transactions View source PDF

MEDANTA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+3.0%1-day move
₹1100.10
prior close
₹1158.55
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.1+0.3+0.2+0.4+3.0+3.3+1.8+6.4+6.5+10.4+12.2+10.2+18.3+28.3
Up moveDown movePending
AI summary

Global Health Limited (Medanta) has approved acquisition of a 79-bedded cancer care hospital in Indore through a Business Transfer Agreement. The target hospital, currently operated by Asian Institute of Oncology Private Limited (AIOPL), will be acquired for Rs. 30 crores in cash. The hospital had turnover of Rs. 19.9 million for FY 2024-25. Medanta will also execute a fresh lease for an additional 1,700 sqft space. The acquisition is not a related party transaction and will be funded by internal accruals and debt. The transaction is expected to close much before the September 30, 2026 long stop date, subject to statutory approvals.

Likely market impact

This acquisition adds 79 beds (2.2% increase to existing 3,579 beds) to Medanta's network and strengthens its oncology portfolio in Indore, leveraging synergies from proximity to its existing facility just 500 meters away.